Biomechanical comparison of glenoid implants with adaptable and fixed backside curvatures in anatomic total shoulder arthroplasty.

We evaluated the biomechanical effects and potential advantages of glenoid implants with adaptable backside curvature radii and compared them with standard implants having fixed backside curvatures in anatomic total shoulder arthroplasty (aTSA) for primary glenohumeral osteoarthritis with uniconcave glenoids. A glenoid implant with adaptable backside curvatures (Aequalis PerFORM, Tornier SAS, Montbonnot, France) was compared with its previous model having a fixed curvature radius. Virtual aTSAs were performed in 24 patients from preoperative shoulder computed tomography data sets, using both implants in each patient. For all 48 simulated aTSAs, we first measured the glenoid bone reaming depth, subchondral bone quality after reaming, and implant backside surface and then the predicted cement stress, bone-cement interfacial stress, and bone strain at 60° of arm abduction. These biomechanical quantities were tested for differences between adaptable and fixed implants and for correlations between preoperative measurements and postoperative predictions. Adaptable glenoid implants induced a significant decrease in cement stress (P = .008), bone-cement interfacial stress (P = .045), and bone strain (P = .039), particularly for glenoids with curvature radii larger than 40 mm. However, these biomechanical effects were not significantly correlated with an increase in subchondral glenoid bone quality. Our study confirms the presumed biomechanical advantages of adaptable glenoid implants, even though the effects were not directly due to the adaptation of the backside curvature radius. Benefits were more pronounced for glenoids with large curvature radii. Our initial biomechanical findings should now be corroborated with large-scale clinical studies.

Terrier A ，Obrist R ，Malfroy Camine V ，Becce F ，Farron A ... -  《-》

Cement stress predictions after anatomic total shoulder arthroplasty are correlated with preoperative glenoid bone quality.

We hypothesized that biomechanical parameters typically associated with glenoid implant failure after anatomic total shoulder arthroplasty (aTSA) would be correlated with preoperative glenoid bone quality. We developed an objective automated method to quantify preoperative glenoid bone quality in different volumes of interest (VOIs): cortical bone, subchondral cortical plate, subchondral bone after reaming, subchondral trabecular bone, and successive layers of trabecular bone. Average computed tomography (CT) numbers (in Hounsfield units [HU]) were measured in each VOI from preoperative CT scans. In parallel, we built patient-specific finite element models of simulated aTSAs to predict cement stress, bone-cement interfacial stress, and bone strain around the glenoid implant. CT measurements and finite element predictions were obtained for 20 patients undergoing aTSA for primary glenohumeral osteoarthritis. We tested all linear correlations between preoperative patient characteristics (age, sex, height, weight, glenoid bone quality) and biomechanical predictions (cement stress, bone-cement interfacial stress, bone strain). Average CT numbers gradually decreased from cortical (717 HU) to subchondral and trabecular (362 HU) bone. Peak cement stress (4-10 MPa) was located within the keel hole, above the keel, or behind the glenoid implant backside. Cement stress, bone-cement interfacial stress, and bone strain were strongly negatively correlated with preoperative glenoid bone quality, particularly in VOIs behind the implant backside (subchondral trabecular bone) but also in deeper trabecular VOIs. Our numerical study suggests that preoperative glenoid bone quality is an important parameter to consider in aTSA, which may be associated with aseptic loosening of the glenoid implant. These initial results should now be confronted with clinical and radiologic outcomes.

Terrier A ，Obrist R ，Becce F ，Farron A ... -  《-》

Evaluation of thirty eight cemented pegged glenoid components with variable backside curvature: two-year minimum follow-up.

Dauzère F ，Arboucalot M ，Lebon J ，Elia F ，Bonnevialle N ，Mansat P ... -  《-》

Stepped Augmented Glenoid Component in Anatomic Total Shoulder Arthroplasty for B2 and B3 Glenoid Pathology: A Study of Early Outcomes.

Posterior glenoid bone loss is commonly associated with primary glenohumeral osteoarthritis. Surgical management of bone loss in anatomic total shoulder arthroplasty (aTSA) remains controversial. We studied the use of a stepped augmented glenoid component for management of Walch B2 and B3 glenoids and compared the radiographic and clinical outcomes at short-term follow-up with those achieved with a non-augmented component of the same design in Walch A1 glenoids. Ninety-two patients (42 A1, 29 B2, and 21 B3 glenoids) were prospectively followed after aTSA. Sequential 3-dimensional (3D) computed tomography (CT) imaging was performed preoperatively, within 3 months postoperatively with metal artifact reduction (MAR) to define implant position, and at a minimum of 2 years postoperatively with MAR. Scapular 3D registration with implant registration allowed 3D measurement of glenoid implant position, implant shift, and central peg osteolysis (CPO). CPO with or without implant shift occurred in a higher percentage of B3 glenoids treated with the augmented glenoid component (29%) than A1 glenoids treated with a standard component (5%) (p = 0.028). There was no significant difference in the frequency of CPO between B2 glenoids with the augmented component (10%) and A1 glenoids with the standard component. There was no difference in postoperative glenoid component version and inclination between groups. B3 glenoids were associated with more component medialization relative to the premorbid joint line compared with A1 and B2 glenoids (p < 0.001). A stepped augmented glenoid component can restore premorbid glenoid anatomy in patients with asymmetric biconcave glenoid bone loss (Walch B2), with short-term clinical and radiographic results equivalent to those for patients without glenoid bone loss (Walch A1) treated with a non-augmented component. There is a greater risk of CPO in patients with moderate-to-severe B3 glenoid pathology with this stepped augmented glenoid component. Longer follow-up will help define the clinical implications of CPO over time. Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Iannotti JP ，Jun BJ ，Derwin KA ，Ricchetti ET ... -  《-》

Is preoperative glenoid bone mineral density associated with aseptic glenoid implant loosening in anatomic total shoulder arthroplasty?

Mariaux S ，Obrist R ，Farron A ，Becce F ，Terrier A ... -  《BMC MUSCULOSKELETAL DISORDERS》